Skip to main content
. 2016 Apr 27;7(23):34022–34037. doi: 10.18632/oncotarget.9067

Figure 2. Expressional changes of TRIM29, RAN, and SQSTM1 in NPC tissues and their efficacy in discriminating metastatic NPC from non-metastatic NPC.

Figure 2

A. A representative result of immunohistochemistry shows the expression of RAN, SQSTM1, and TRIM29 in the metastatic NPC and non-metastatic NPC. Original magnification: ×200. B. Receiver operating characteristic (ROC) curves of RAN, SQSTM1, TRIM29 in discriminating metastatic NPC from non-metastatic NPC.